Orexo AB is a Swedish pharmaceutical company based in Uppsala that develops and commercialises medicines, chiefly in the area of addiction and pain. Its main product is a tablet treatment for opioid dependence, and it also works on other drug delivery technologies and specialty pharmaceuticals. The company serves patients and healthcare providers, mainly through partners and its own commercial operations in selected markets such as the United States and Europe.
Orexo AB trades under the code ORX on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #845 of 911 on the Stockholm Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendWeak
4/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-73.1%
From 52-week high-86.3%
MomentumWeak
4/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-64.3%
6-month return-73.5%
12-month, skipping last month-66.8%
Stability (higher is calmer)Weak
15/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)84.4%
Worst drawdown, 1 year (smaller is calmer)-86.3%
LiquidityFair
57/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.80M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 5.420 – 40.150Daily closes, split-adjusted
Signals
50-day average12.194
200-day average20.129
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.825
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
6.19
Bearish
EMA 10
6.80
Bearish
SMA 20
9.45
Bearish
EMA 20
8.56
Bearish
SMA 50
12.19
Bearish
EMA 50
11.61
Bearish
SMA 100
15.79
Bearish
EMA 100
14.62
Bearish
SMA 200
20.13
Bearish
EMA 200
17.83
Bearish
Oscillators (daily)
RSI (14)
13.50
Bullish
MACD (12, 26)
-2.16
Bearish
Momentum (12)
-59.55
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-76.79
Neutral
Pivot points (classic, last session)
S3
4.79
S2
5.11
S1
5.26
Pivot
5.58
R1
5.73
R2
6.05
R3
6.20
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
